Reports & Papers

Direct air capture (DAC) is a type of technology that captures carbon dioxide directly from the air. As the negative impacts of climate change become ever more apparent, governments and private industries have funneled increasing support toward DAC as a critical pathway toward achieving a net-zero future. Although a promising technology, wide-scale deployment of DAC faces several significant challenges.

By investing in the public and private sector research and development in this space, and by fostering a community of researchers, entrepreneurs, and investors literate in CO2 capture opportunities, the United States can be the leader of this new economic sector. It is essential for the Nation to build a vibrant and sustained research and development community spanning the public sector, academic and research domains, and for-profit companies, ensuring world leadership in this new technological domain.

This essay makes three arguments. First, the US government will need to establish a coronavirus commission, similar to the 9/11 commission, to determine why, since April 2020, the United States has suffered more coronavirus fatalities than any other country in the world. Second, the COVID-19 pandemic represents a watershed for what will be a major national security theme this century: biological threats, both from naturally occurring pathogens and from synthesized biology. Third, intelligence about globalized challenges, such as pandemics, needs to be dramatically reconceptualized, stripping away outmoded levels of secrecy.

Many are looking to digital contact tracing to assist reopening efforts, especially in light of reports that the U.S. could expect as many as 100,000 more deaths due to the virus by this Fall. This report focuses on how the U.S. might consider various proposed solutions.

We believe there are real benefits, challenges, and even potential harms in using digital solutions in the fight against COVID-19, but we must also acknowledge that the promise of any technology and associated systems to assist manual contact tracing efforts is largely hypothetical in the United States. There is not one catch-all answer; the truth is that technology is not a panacea, but it may be able to assist official efforts at an unprecedented time. However, no technological solution can succeed without two specific factors: public trust and buy-in, and rapid, widespread testing for everyone living in the U.S. To achieve the first, a number of factors must be addressed by officials in the states looking to implement digital solutions, and by technology developers.
 

In this piece, we will look at the various public purpose considerations as they relate to the development of diagnostics, therapeutics, and vaccines for coronavirus. 

With reservations about venturing into territory outside our normal wheelhouse, and in full certainty that some of what we write here will in retrospect turn out to have been wrong, a team of researchers at the Belfer Center and I have been collecting all the data we have been able to find about coronavirus, analyzing it to the best of our ability, and debating competing answers to the fundamental questions about the challenge this novel virus poses to our nation.

What follows is our current first-approximation of a work in progress. We are posting at this point in the hope of stimulating a wider debate that will include a much larger number of analysts beyond public health professionals and epidemiologists—including in particular intelligence officers, financial wizards, historians, and others.

The Technology Factsheet Series offers a brief overview of the technical aspects of salient technologies and their policy relevance for Congressional members and their staff.